ANIP ANI PHARMACEUTICALS INC
2026Q1 · CUSIP 00182C103 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
276
Δ holders QoQ
-5
Breadth percentile
Top 78%
Whale holders
140
Δ whales
+2
Inst. holding value
$1.8B
New positions
44
Closed positions
49
Price momentum (1Q)
+0.6%
Put / Call
3/4
Breadth history (34 quarters)
Past Lit Events & Aftermath 8 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q3 | Top 8% | -4.7% | +0.0% |
| 2025Q1 | Top 9% | +49.8% | +36.3% |
| 2024Q1 | Top 17% | -0.3% | -7.9% |
| 2023Q3 | Top 12% | +13.9% | +20.4% |
| 2023Q2 | Top 5% | -10.4% | -3.1% |
| 2023Q1 | Top 14% | +34.7% | +17.5% |
| 2019Q1 | Top 15% | -2.0% | -20.4% |
| 2018Q1 | Top 19% | -13.6% | -19.4% |
Options Sentiment
Put holders
3
QoQ: -1
Call holders
4
QoQ: -1
See methodology →
Fundamentals
PE (TTM)
20.3
EPS (TTM)
$3.91
EPS YoY
—
Revenue (TTM)
$0.9B
Revenue YoY
+37.0%
Net margin
10.0%
ROE
16.4%
Debt ratio
60.5%
FCF (TTM)
$191M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.